BCRX · Company research
BioCryst Pharmaceuticals Inc (BCRX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 7.95 | $2,277,767,350 | 2122795350.00 | 28.6333333333333333 | — | 0.02045238095238095236 | 10.4365056128293242 | — | 21.87363611919372341143 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.